EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-Resistant Tuberculosis Outcomes in South Kivu Province, Democratic Republic of Congo, During a Humanitarian Crisis (2018–2024)

Eric Mulume Musafiri iD, Barhwamire Théophile Kabesha, Freddy Birembano, Rosette Nyota, Maryska Chimanuka Mapendo, Jean Paul Chirambiza, Trésor Kashinde Mosomo, Edmond Ntabe Namegabe

Open Forum Infectious Diseases · 28.04.2026 · 13 (5)

DOI: 10.1093/ofid/ofag303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 14.05.2026. Verfasst von Eric Mulume Musafiri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drug Resistance Unit, National Tuberculosis Program Democratic Republic of the Congo (DRC), Bukavu, DRC. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Tuberculosis Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-resistant tuberculosis (DR-TB) management in fragile, conflict-affected settings remains challenging. South Kivu Province has faced protracted insecurity and recent outbreaks (COVID-19, mpox). We assessed treatment outcomes and predictors among DR-TB patients managed under programmatic conditions.

Methods

We conducted a retrospective provincial cohort study of all patients registered in electronic Tuberculosis registry with DR-TB in South Kivu from January 2018 to June 2024. Primary outcome was treatment success; unsuccessful outcomes. We summarized characteristics, performed Kaplan–Meier functions for time to outcome, and fitted multivariable logistic regression and Cox proportional hazards models to identify predictors of unsuccessful outcomes.

Results

Among 277 DR-TB patients (median age 37 years; 3–75), overall treatment success was 77.6%, mortality 13.4%, and loss to follow-up (LTFU) 8.6%. HIV status was negative in 79.1% and positive in 9.4%. Bedaquiline-containing regimens were used in 100%. In adjusted analyses, rural residence was protective against unsuccessful outcome (aOR 0.42; 95% CI 0.21–0.82; P = .011), whereas retreatment other than relapse was associated with higher odds of unsuccessful outcome (aOR 2.04; 95% CI 1.09–3.81; P = .026). Findings were consistent in time-to-event models (rural aHR 0.50; 95% CI 0.29–0.85; P = .011; retreatment aHR 1.71; 95% CI 1.03–2.83; P = .038).

Conclusions

In a humanitarian crisis context, programmatic all-oral DR-TB care achieved success exceeding the WHO ≥ 75% target. Persistently high mortality and LTFU—concentrated among urban residents and retreatment (non-relapse) cases—highlight the need for targeted urban patient-tracing, strengthened referral/continuity mechanisms, and uninterrupted drug supply. Results support scale-up of short, all-oral regimens with context-specific adherence support in fragile settings.

Schlagwörter

Stichwörter der Autor:innen

DR-TBhumanitarian settingstreatment outcomes

Autor:innen und Institutionen

  • Drug Resistance Unit, National Tuberculosis Program Democratic Republic of the Congo (DRC), Bukavu, DRC.
  • Department of Medicine, Université Officielle de Bukavu, Bukavu, DRC.
  • Department of Public Health, Institut Supérieur de Techniques Médicales de Kaziba, Kaziba, DRC.
  • Faculté de Médecine, Université Officielle de Bukavu, Bukavu, DRC.
  • Department of Internal Medicine, Hôpital Général de Référence de Miti-Murhesa, Sud Kivu, DRC.
  • Expertise France, Project RESOH-Lab, Bureau de Bukavu, Bukavu, DRC.

ORCID-Profile: Eric Mulume Musafiri

Förderung

  • National Tuberculosis Program

Zitieren

APA

Musafiri, E. M., Kabesha, B. T., Birembano, F., Nyota, R., Mapendo, M. C., Chirambiza, J. P., Mosomo, T. K., & Namegabe, E. N. (2026). Drug-Resistant Tuberculosis Outcomes in South Kivu Province, Democratic Republic of Congo, During a Humanitarian Crisis (2018–2024). Open Forum Infectious Diseases, 13(5). https://doi.org/10.1093/ofid/ofag303

Vancouver

Musafiri EM, Kabesha BT, Birembano F, Nyota R, Mapendo MC, Chirambiza JP, et al. Drug-Resistant Tuberculosis Outcomes in South Kivu Province, Democratic Republic of Congo, During a Humanitarian Crisis (2018–2024). Open Forum Infectious Diseases. 2026;13(5). doi:10.1093/ofid/ofag303

BibTeX
@article{Musafiri2026,
  author = {Musafiri, Eric Mulume and Kabesha, Barhwamire Théophile and Birembano, Freddy and Nyota, Rosette and Mapendo, Maryska Chimanuka and Chirambiza, Jean Paul and Mosomo, Trésor Kashinde and Namegabe, Edmond Ntabe},
  title = {Drug-Resistant Tuberculosis Outcomes in South Kivu Province, Democratic Republic of Congo, During a Humanitarian Crisis (2018–2024)},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {5},
  doi = {10.1093/ofid/ofag303}
}
Kostenlos starten →